{"id":"W3012526746","doi":"10.1200/jco.2013.31.15_suppl.3633","title":"A phase I study of sorafenib with FOLFIRI as first-line therapy for metastatic colorectal cancer (mCRC): Safety and efficacy results.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Irinotecan; FOLFIRI; Neutropenia; Internal medicine; Gastroenterology; Sorafenib; Mucositis; Colorectal cancer; Adverse effect; Nausea; Febrile neutropenia; Anemia; Surgery; Toxicity; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003061412,0.002407739,0.002595705,0.0007691804,0.0006259003,0.001179113,0.001392074,0.001733515,0.003401974],"category_scores_gemma":[0.001677276,0.001070924,0.001901182,0.0006619687,0.001570781,0.001051239,0.0004596572,0.00394281,0.0008403535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001257062,"about_ca_system_score_gemma":0.002621131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001468441,"about_ca_topic_score_gemma":0.002869384,"domain_scores_codex":[0.9991152,0.0004527926,0.00003726341,0.0001282879,0.0001063794,0.0001601032],"domain_scores_gemma":[0.9985257,0.0002154186,0.0002330268,0.0001461827,0.00007484025,0.0008048365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6578027,0.2079137,0.00503409,0.000954042,0.001499788,0.0005412314,0.0005429429,0.002602603,0.0556367,0.0002921453,0.004454605,0.06272554],"study_design_scores_gemma":[0.4843089,0.5032446,0.005597702,0.00002641377,0.0003760014,0.0003201509,0.00004119751,0.0007683995,0.003760873,0.0001125869,0.001416509,0.00002667372],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908777,0.002223225,0.000727538,0.0004341174,0.0001477937,0.003508115,0.0009952534,0.0001126679,0.0009735181],"genre_scores_gemma":[0.9824484,0.002901174,0.003300032,0.0008034683,0.0002806558,0.003807279,0.003425586,0.00005116803,0.002982359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003401974,"threshold_uncertainty_score":0.01619047,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1336984831371067,"score_gpt":0.4993151273842381,"score_spread":0.3656166442471314,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}